SURVIVAL AFTER ALLOGENOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML) IS NOT INFLUENCED BY PRETRANSPLANT INTERFERON-ALPHA THERAPY

Citation
R. Hehlmann et al., SURVIVAL AFTER ALLOGENOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML) IS NOT INFLUENCED BY PRETRANSPLANT INTERFERON-ALPHA THERAPY, British Journal of Haematology, 102(1), 1998, pp. 317-317
Citations number
NO
Categorie Soggetti
Hematology
ISSN journal
00071048
Volume
102
Issue
1
Year of publication
1998
Supplement
S
Pages
317 - 317
Database
ISI
SICI code
0007-1048(1998)102:1<317:SAABTI>2.0.ZU;2-5